» Articles » PMID: 37075331

Immune System Modulation by Low-dose Ionizing Radiation-induced Adaptive Response

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hormesis or low-dose ionizing radiation is known to induce various biological responses, a subcategory of which is the adaptive response, which has been reported to protect against higher radiation doses via multiple mechanisms. This study investigated the role of the cell-mediated immunological component of low-dose ionizing radiation-induced adaptive response.

Methods: Herein, male albino rats were exposed to whole-body gamma radiation, using a Cs source with low-dose ionizing radiation doses of 0.25 and 0.5 Gray (Gy); 14 days later, another irradiation session at a dose level of 5 Gy was carried on. Four days post-irradiation at 5 Gy, rats were sacrificed. The low-dose ionizing radiation-induced immuno-radiological response has been assessed through the T-cell receptor (TCR) gene expression quantification. Also, the serum levels of each of interleukins-2 and -10 (IL-2, IL-10), transforming growth factor-beta (TGF-β), and 8-hydroxy-2'-deoxyguanosine (8-OHdG) were quantified.

Results: Results indicated that priming low irradiation doses resulted in significant decrements in TCR gene expression and the serum levels of IL-2, TGF-β, and 8-OHdG with an increment in IL-10 expression compared to the irradiated group, which did not receive low priming doses.

Conclusion: The observed low-dose ionizing radiation-induced radio-adaptive response significantly protected against high irradiation dose injuries, through immune suppression, representing a promising pre-clinical protocol that would be applied to minimize radiotherapy side effects on normal but not against the tumor cells.

Citing Articles

Low-Dose Ionizing Radiation and Male Reproductive Immunity: Elucidating Subtle Modulations and Long-Term Health Implications.

Yin J, Ye Y, Gao Y, Xu Q, Su M, Sun S Int J Mol Sci. 2025; 26(5).

PMID: 40076897 PMC: 11900348. DOI: 10.3390/ijms26052269.


Alzheimer's disease and low-dose radiation therapy: A new hope.

Dunlap N, Friedland R, Cai L Radiat Med Prot. 2024; 5(1):1-6.

PMID: 38585336 PMC: 10997373. DOI: 10.1016/j.radmp.2024.01.002.


A new target of radiotherapy combined with immunotherapy: regulatory T cells.

Song D, Ding Y Front Immunol. 2024; 14:1330099.

PMID: 38259489 PMC: 10800811. DOI: 10.3389/fimmu.2023.1330099.


Deficiency of salt-inducible kinase 2 (SIK2) promotes immune injury by inhibiting the maturation of lymphocytes.

Zhu J, Li C, Wang P, Liu Y, Li Z, Chen Z MedComm (2020). 2023; 4(5):e366.

PMID: 37706195 PMC: 10495731. DOI: 10.1002/mco2.366.

References
1.
Conley J, Gallagher M, Berg L . T Cells and Gene Regulation: The Switching On and Turning Up of Genes after T Cell Receptor Stimulation in CD8 T Cells. Front Immunol. 2016; 7:76. PMC: 4770016. DOI: 10.3389/fimmu.2016.00076. View

2.
Nenoi M, Wang B, Vares G . In vivo radioadaptive response: a review of studies relevant to radiation-induced cancer risk. Hum Exp Toxicol. 2014; 34(3):272-83. PMC: 4442823. DOI: 10.1177/0960327114537537. View

3.
Marnett L, Riggins J, West J . Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest. 2003; 111(5):583-93. PMC: 151910. DOI: 10.1172/JCI18022. View

4.
Lee N, Shin M, Kang I . T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci. 2012; 67(3):254-63. PMC: 3297764. DOI: 10.1093/gerona/glr237. View

5.
Rodel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G . Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007; 83(6):357-66. DOI: 10.1080/09553000701317358. View